Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy

Journal of Applied Physiology

Volumn 118, Issue 2, 2015, Pages 200-211

  De Theije, C C ^a   Langen, R C J ^a   Lamers, W H ^a   Gosker, H R ^a   Schols, A M W J ^a   Kohler S E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glycolytic muscle; Hypoxia; Oxidative muscle; Protein degradation pathways

Indexed keywords

GLUCOCORTICOID; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UBIQUITIN PROTEIN LIGASE;

ADAPTATION; ANIMAL; ANOXIA; AUTOPHAGY; C57BL MOUSE; COMPLICATION; GENE EXPRESSION; GLYCOLYSIS; LYSOSOME; MALE; METABOLISM; MUSCLE; MUSCULAR ATROPHY; OXIDATION REDUCTION REACTION; PATHOLOGY; RANDOMIZATION; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; AUTOPHAGY; GENE EXPRESSION; GLUCOCORTICOIDS; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYSOSOMES; MALE; MICE, INBRED C57BL; MUSCLES; MUSCULAR ATROPHY; OXIDATION-REDUCTION; RANDOM ALLOCATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84921417650     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00624.2014     Document Type: Article

References (59)

1. Batt J, Ahmed SS, Correa J, Bain A, Granton J. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Resp Cell Mol Biol 50: 74-86, 2014.
2. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouysségur J, Mazure NM. Hypoxia-induced autophagy is mediated through hypoxia- inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581, 2009.
3. BioGPS. VEGF-A gene expression profile. http://biogps.org/-goto-generreport&id-7422 [6 Dec. 2014].
4. Bishop B, Silva G, Krasney J, Nakano H, Roberts A, Farkas G, Rifkin D, Shucard D. Ambient temperature modulates hypoxic-induced changes in rat body temperature and activity differentially. Am J Physiol Regul Integr Comp Physiol 280: R1190-R1196, 2001.
5. Boutellier U, Howald H, di Prampero PE, Giezendanner D, Cerretelli P. Human muscle adaptations to chronic hypoxia. Prog Clin Biol Res 136: 273-285, 1983.
6. Bredman JJ, Wessels A, Weijs WA, Korfage JA, Soffers CA, Moorman AF. Demonstration of 'cardiac-specific' myosin heavy chain in masticatory muscles of human and rabbit. Histochem J 23: 160-170, 1991.
7. Breen E, Tang K, Olfert M, Knapp A, Wagner P. Skeletal muscle capillarity during hypoxia: VEGF and its activation. High Alt Med Biol 9: 158-166, 2008.
8. Burkholder TJ, Fingado B, Baron S, Lieber RL. Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 221: 177-190, 1994.
9. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med 99 Suppl B: S3-S10, 2005.
10. de Theije CC, Langen RC, Lamers WH, Schols AM, Koehler SE. Distinct responses of protein turnover-regulatory pathways in hypoxiaand semi-starvation-induced muscle atrophy. Am J Physiol Lung Cell Mol Physiol 305: L82-L91, 2013.
11. Deveci D, Marshall JM, Egginton S. Relationship between capillary angiogenesis, fiber-type, and fiber size in chronic systemic hypoxia. Am J Physiol Heart Circ Physiol 281: H241-H252, 2001.
12. Eliason G, Abdel-Halim SM, Piehl-Aulin K, Kadi F. Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease. Respir Res 11: 97, 2010.
13. Gamboa JL, Garcia-Cazarin ML, Andrade FH. Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol 300: R85-R91, 2011.
14. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984, 2005.
15. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98: 14440-14445, 2001.
16. Gosker HR, Engelen MPKJ, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EFM, Schols AMWJ. Muscle fiber-type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76: 113-119, 2002.
17. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EF, Schols AM. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19: 617-625, 2002.
18. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62: 944-949, 2007.
19. Gray S, Wang B, Orihuela Y, Hong EG, Fisch S, Haldar S, Cline GW, Kim JK, Peroni OD, Kahn BB, Jain MK. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab 5: 305-312, 2007.
20. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 153: 961-966, 1996.
21. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz- Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683-693, 2003.
22. Hickson RC, Wegrzyn LE, Osborne DF, Karl IE. Glutamine interferes with glucocorticoid-induced expression of glutamine synthetase in skeletal muscle. Am J Physiol Endocrinol Metab 270: E912-E917, 1996.
23. Itoh K, Moritani T, Ishida K, Hirofuji C, Taguchi S, Itoh M. Hypoxiainduced fibre type transformation in rat hindlimb muscles. Histochemical and electro-mechanical changes. Eur J Appl Physiol Occup Physiol 60: 331-336, 1990.
24. Jobin J, Maltais F, Doyon JF, LeBlanc P, Simard PM, Simard AA, Simard C. Chronic obstructive pulmonary disease: capillarity and fibertype characteristics of skeletal muscle. J Cardiopulm Rehabil 18: 432-437, 1998.
25. Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544, 2012.
26. Kon M, Ohiwa N, Honda A, Matsubayashi T, Ikeda T, Akimoto T, Suzuki Y, Hirano Y, Russell AP. Effects of systemic hypoxia on human muscular adaptations to resistance exercise training. Physiol Reports 2: e12033, 2014.
27. Koncarevic A, Jackman RW, Kandarian SC. The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension. Faseb J 21: 427-437, 2007.
28. Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2: 1117-1133, 2011.
29. Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, Kosnik M, Anker SD, Suskovic S. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2: 81-86, 2011.
30. Leonard MO, Godson C, Brady HR, Taylor CT. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol 174: 2250-2257, 2005.
31. Livingstone I, Johnson MA, Mastaglia FL. Effects of dexamethasone on fibre subtypes in rat muscle. Neuropathol Appl Neurobiol 7: 381-398, 1981.
32. Lunde IG, Anton SL, Bruusgaard JC, Rana ZA, Ellefsen S, Gundersen K. Hypoxia inducible factor 1 links fast-patterned muscle activity and fast muscle phenotype in rats. J Physiol 589: 1443-1454, 2011.
33. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez- Cadavid N, Arias J, Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285: E363-E371, 2003.
34. Macpherson PC, Wang X, Goldman D. Myogenin regulates denervation- dependent muscle atrophy in mouse soleus muscle. J Cell Biochem 112: 2149-2159, 2011.
35. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2: 216-224, 2001.
36. Max SR, Thomas JW, Banner C, Vitkovic L, Konagaya M, Konagaya Y. Glucocorticoid receptor-mediated induction of glutamine synthetase in skeletal muscle cells in vitro. Endocrinology 120: 1179-1183, 1987.
37. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol (1985) 101: 898-905, 2006.
38. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 27: 421-429, 2002.
39. Murakami S, Fujino H, Takeda I, Momota R, Kumagishi K, Ohtsuka A. Comparison of capillary architecture between slow and fast muscles in rats using a confocal laser scanning microscope. Acta Medica Okayama 64: 11-18, 2010.
40. Natanek SA, Riddoch-Contreras J, Marsh GS, Hopkinson NS, Moxham J, Man WD, Kemp PR, Polkey MI. MuRF-1 and Atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. COPD 10: 618-624, 2013.
41. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341: 309-315, 1998.
42. Park CW, Ryu KY. Cellular ubiquitin pool dynamics and homeostasis. BMB Rep 47: 475-482, 2014.
43. Pereira ER, Frudd K, Awad W, Hendershot LM. Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF). J Biol Chem 289: 3352-3364, 2014.
44. Pereira MC, Isayama RN, Seabra JC, Campos GE, Paschoal IA. Distribution and morphometry of skeletal muscle fibers in patients with chronic obstructive pulmonary disease and chronic hypoxemia. Muscle Nerve 30: 796-798, 2004.
45. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91: 226-231, 2002.
46. Roy RR, Gardiner PF, Simpson DR, Edgerton VR. Glucocorticoidinduced atrophy in different fibre types of selected rat jaw and hind-limb muscles. Arch Oral Biol 28: 639-643, 1983.
47. Sandri M. Autophagy in skeletal muscle. FEBS Lett 584: 1411-1416, 2010.
48. Sato S, Suzuki H, Tsujimoto H, Shirato K, Tachiyashiki K, Imaizumi K. Casted-immobilization downregulates glucocorticoid receptor expression in rat slow-twitch soleus muscle. Life Sci 89: 962-967, 2011.
49. Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid- induced skeletal muscle atrophy. Int J Biochem Cell Biol 45: 2163-2172, 2013.
50. Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda Si Nakae J, Tagata Y, Nishitani S, Takehana K, Sano M, Fukuda K, Suematsu M, Morimoto C, Tanaka H. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13: 170-182, 2011.
51. Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J 9: 2584-2589, 1996.
52. Stavreva DA, Varticovski L, Hager GL. Complex dynamics of transcription regulation. Biochim Biophys Acta 1819: 657-666, 2012.
53. van den Borst B, Schols AM, de Theije C, Boots AW, Köhler SE, Goossens GH, Gosker HR. Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia. J Appl Physiol 114: 1619-1628, 2013.
54. Vilar J, Waeckel L, Bonnin P, Cochain C, Loinard C, Duriez M, Silvestre JS, Levy BI. Chronic hypoxia-induced angiogenesis normalizes blood pressure in spontaneously hypertensive rats. Circ Res 103: 761-769, 2008.
55. Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. Am J Physiol Endocrinol Metab 302: E1210-E1220, 2012.
56. Weckbach LT, Groesser L, Borgolte J, Pagel JI, Pogoda F, Schymeinsky J, Muller-Hocker J, Shakibaei M, Muramatsu T, Deindl E, Walzog B. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol 303: H429-H438, 2012.
57. Wouters EF. Nutrition and metabolism in COPD. Chest 117: 274S-280S, 2000.
58. Wust RC, Jaspers RT, van Heijst AF, Hopman MT, Hoofd LJ, van der Laarse WJ, Degens H. Region-specific adaptations in determinants of rat skeletal muscle oxygenation to chronic hypoxia. Am J Physiol Heart Circ Physiol 297: H364-H374, 2009.
59. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL. Mitochondrial autophagy is an HIF-1- dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903, 2008.